Results 151 to 160 of about 3,221,536 (372)

Association Between Moraxella catarrhalis and Nodular Lymphocyte‐Predominant Hodgkin Lymphoma

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Nodular lymphocyte‐predominant Hodgkin Lymphoma (NLPHL) may be an antigen‐driven malignancy. Recent studies demonstrated that in NLPHL patients, lymphoma B‐cell receptor can bind proteins derived from Moraxella catarrhalis (MC) and Rothia mucilaginosa (RM). We examined whether MC and RM can be detected in NLPHL lymph nodes.
Izidore S. Lossos   +7 more
wiley   +1 more source

Impact of Cytogenetic Response to Therapy on Long‐Term Survival in Acute Myeloid Leukemia

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Prognostication in acute myeloid leukemia (AML) relies on clinical, molecular, and cytogenetic factors. In this retrospective study, we examined the impact of different levels of cytogenetic response on overall survival (OS) and event‐free survival (EFS) in AML.
John Hanna   +22 more
wiley   +1 more source

Is hemostatic agent effective and safe in minimally invasive partial nephrectomy? [PDF]

open access: yesChin Med J (Engl), 2022
Guo Q   +9 more
europepmc   +1 more source

روشهای مورد استفاده در کنترل خونریزی کبدی [PDF]

open access: yes, 2014
برقراری هموستاز سریع و مناسب در ارگان¬های پارانشیمی، خصوصاً در بافت کبدی کار بسیار دشواری می¬باشد. مشکل اصلی در کنترل خونریزی کبد، توقف تراوش خون از ساختار سینوزوئیدال بافت کبد می¬باشد که دارای عروق بسیار کوچکی می¬باشد و در نتیجه بستـن عـروق بسیار مشکل ...
شریف, محمد رضا   +1 more
core  

Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP

open access: yesAmerican Journal of Hematology, EarlyView.
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert   +29 more
wiley   +1 more source

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari   +22 more
wiley   +1 more source

An autologous blood-derived patch as a hemostatic agent: evidence from thromboelastography experiments and a porcine liver punch biopsy model. [PDF]

open access: yesJ Mater Sci Mater Med, 2023
Eskildsen MPR   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy